Jia-Yi Shen

Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types

Panpan Zhang, R. Guo, Yupei Chen, 2020, Journal of Hematology & Oncology.

Low‐dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma

Ying Sun, Jun Ma, Yupei Chen, 2022, Cancer communications.

TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma

Jun Ma, Ziwei Huang, Yupei Chen, 2023, Science advances.

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses

Y. Mao, Qingmei He, Xiao-jing Yang, 2021, Molecular cancer.

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses

Ying Sun, Y. Mao, Qingmei He, 2021, Molecular Cancer.

The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment

Ying Sun, Y. Mao, Qingmei He, 2023, Nature Medicine.